NASDAQ:ESTA
Establishment Labs Holdings Inc. Stock News
$44.48
-0.240 (-0.537%)
At Close: Jun 14, 2024
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
08:00am, Thursday, 23'rd May 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
06:11pm, Wednesday, 08'th May 2024
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to loss of $0.48 per share a year ago.
Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024
08:30am, Thursday, 02'nd May 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
08:30am, Wednesday, 01'st May 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
08:30am, Wednesday, 24'th Apr 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
08:30am, Wednesday, 17'th Apr 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Holdings Inc. (ESTA) Q4 2023 Earnings Call Transcript
11:45pm, Wednesday, 28'th Feb 2024
Establishment Labs Holdings Inc. (ESTA) Q4 2023 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
06:31pm, Wednesday, 28'th Feb 2024
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.95. This compares to loss of $0.55 per share a year ago.
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
08:00am, Friday, 23'rd Feb 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Announces Amended Credit Facility with Oaktree
08:00am, Thursday, 22'nd Feb 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, today
Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
11:06am, Wednesday, 21'st Feb 2024
Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Establishment Labs Announces Commercial Launch of Motiva Implants in China
08:00am, Monday, 22'nd Jan 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA) (“Establishment Labs” or the “Company”), a global medical technology company dedicated to improving women's health an
Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander
08:00am, Tuesday, 02'nd Jan 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs to Present at the 42nd Annual J.P. Morgan Healthcare Conference
08:30am, Thursday, 28'th Dec 2023
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
